Sofyan Radaideh, MD
Hematology & Oncology · Pueblo, CONPI 1477711901
Payments from drug & device makers
Across 19 payments — averaging $1450.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$28K
- Novocure Inc.$23
- Tosoh Bioscience, Inc.$13
- Gilead$12
- Clovis Oncology, Inc.$10
What the payments were for
- Food & beverage$2339%
- Education$2238%
- Gifts$1323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $27,508 |
| Novocure Inc. | 1 | $23 |
| Tosoh Bioscience, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $10 |
How this compares
$27,566 in reported general payments places this provider in the 50th percentile of 169 hematology & oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 42 | $837,572 |
| Lenalidomide | 26 | $369,816 |
| PomalystPomalidomide | 12 | $318,845 |
| Everolimus | 13 | $23,006 |
| Abiraterone Acetate | 36 | $19,464 |
| Imatinib Mesylate | 16 | $7,911 |
| Megestrol Acetate | 17 | $1,307 |
| Hydroxyurea | 28 | $1,130 |
| Dexamethasone | 43 | $937 |
| Potassium Chloride | 20 | $807 |
| Anastrozole | 42 | $692 |
| Acyclovir | 36 | $530 |
| Ondansetron Hcl | 35 | $389 |
| Prednisone | 41 | $236 |
| Olanzapine | 25 | $207 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Pueblo
- David AndorskyBoulder$31.5M
- John BurkeAurora$25.4M
- Elena ShagisultanovaAurora$22.4M
- Allen CohnDenver$13.5M
- Elaine LamAurora$12.6M
- Robert RifkinDenver$11.3M
- Robert JotteLone Tree$9.4M
- Daniel PollyeaAurora$9.4M
- Henning SchadeDenver$9M
- Manali KamdarAurora$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.